Dudley Robert Michael's Form 4 filing
Transcode Therapeutics, Inc. (RNAZ) · filed Jun 22, 2023
- Accession no.
- 0001104659-23-073872
- Filed
- Jun 22, 2023
- Trade date
- Jun 20-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $48.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudley Robert MichaelCIK 0001854161 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Common Stock | PPurchaseAcquired | +6,607 | $2.55 | +$16,847.85 | 70,262 | Direct | |
| Jun 21, 2023 | Common Stock | PPurchaseAcquired | +12,000 | $2.65 | +$31,800 | 82,262 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.